Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
48 hedge funds and large institutions have $25.1M invested in Infinity Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 5 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
7% more capital invested
Capital invested by funds: $23.4M → $25.1M (+$1.74M)
0% more funds holding
Funds holding: 48 → 48 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$234K |
| 2 |
Millennium Management
New York
|
+$24.4K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$23.8K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$16.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
-$238K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$92.7K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$77.2K |
| 4 |
SC
Savant Capital
Rockford,
Illinois
|
-$21K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| – | +$1 | +1 | New |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| – | +$16 | +17 | New |
|
53
JP Morgan Chase
New York
| – | +$23 | +24 | +2,400% |
|
INFI Hedge Fund Activity: Q2 2020 in Review
48 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q2 2020, worth a combined $25.1M — up 7.4% from $23.4M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new INFI positions and 5 closed out — a net gain of 1 holder — while 13 added to existing stakes and 8 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $234K. The largest seller was Bleichroeder LP, cutting an estimated $238K.
- 48 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $25.1M of Infinity Pharmaceuticals, Inc. stock for Q2 2020, up 7.4% quarter-over-quarter.
- 6 funds opened new Infinity Pharmaceuticals, Inc. positions in Q2 2020 and 5 closed out, a net change of +1 holder.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q2 2020 was Renaissance Technologies, an estimated $234K added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q2 2020 was Bleichroeder LP, an estimated $238K sold.
Based on aggregated 13F filings for Q2 2020.